Propel Bio Management »

Achieve Life Sciences shares owned by Propel Bio Management

Quarter-by-quarter ownership of Achieve Life Sciences (ACHV) shares owned by Propel Bio Management from 13F filings

Historical chart of Propel Bio Management investment in Achieve Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Achieve Life Sciences held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Achieve Life Sciences by Propel Bio Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $11M 2.5M 4.55

More positions owned by Propel Bio Management

Applied Therapeutics Comm (APLT)
Plains Gp Holdings Lp-cl Comm (HIGH)
Tscan Therapeutics Comm (TCRX)
Madrigal Pharmaceuticals Comm (MDGL)
Achieve Life Sciences Comm (ACHV)
Phathom Pharmaceuticals Comm (PHAT)
Akero Therapeutics Comm (AKRO)
Fulcrum Therapeutics Comm (FULC)
Avidity Biosciences Comm (RNA)
Day One Biopharmaceuticals I Comm (DAWN)
Ardelyx Comm (ARDX)
Athira Pharma Comm (ATHA)
Kura Oncology Comm (KURA)
Telesat Corp Comm (TSAT)
Kymera Therapeutics Comm (KYMR)

View all positions for Propel Bio Management

Top funds holding Achieve Life Sciences

Franklin Resources
Propel Bio Management
Sofinnova Ventures
Vanguard Group
ADAR1 Capital Management
Altium Capital Management
Nantahala Capital Management
CVI Holdings
Alyeska Investment Group
Shay Capital
Long Focus Capital Management
Susquehanna International
Simplify Asset Management
Geode Capital Management
Millennium Management

View all funds holding Achieve Life Sciences